← Back to Clinical Trials
Recruiting NCT03607565
NCT03607565 A New Parameter Derived From DSA to Evaluate Cerebral Perfusion
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT03607565 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Xi'an No.3 Hospital |
| Condition | Cerebral Ischemia |
| Study Type | OBSERVATIONAL |
| Enrollment | 30,000 participants |
| Start Date | 2018-07-15 |
| Primary Completion | 2028-07-15 |
Trial Parameters
Condition Cerebral Ischemia
Sponsor Xi'an No.3 Hospital
Study Type OBSERVATIONAL
Phase N/A
Enrollment 30,000
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2018-07-15
Completion 2028-07-15
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This observational study focus on a new parameter of cerebral perfusion derived form digital substraction angiography.
Eligibility Criteria
Inclusion Criteria: 1. Cerebral ischemia 2. patients undergone DSA Exclusion Criteria: 1.cerebral hemorrhage
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology